Detailed investigations of 5-HT3 compounds in a drug discrimination model

被引:22
作者
DeLaGarza, R [1 ]
Callahan, PM [1 ]
Cunningham, KA [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PHARMACOL & TOXICOL,GALVESTON,TX 77555
关键词
cocaine; drug discrimination; 5-HT3; receptors; mCPBG; MDL; 72222; ondansetron; zacopride;
D O I
10.1016/0091-3057(95)02207-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Serotonin type-3 (5-HT3) receptors modulate both dopamine (DA) release and locomotor stimulation induced by cocaine, yet appear to be ineffective at blocking its stimulus and reinforcing effects. To more thoroughly characterize a potential modulatory role of 5-HT3 receptors in the stimulus effects of cocaine, rats (n = 8/group) were trained to discriminate cocaine (10 mg/kg, IP) or the 5-HT3 agonist 1-(meta-chlorophenyl)-biguanide (mCPBG: 15 mg/kg, IP) from saline using a standard drug discrimination task. In rats trained to discriminate cocaine, mCPBG (2.5-20 mg/kg) produced, at best, a partial substitution while mCPBG (10 mg/kg) did not alter the cocaine dose-response relationship. The 5-HT3 antagonists MDL 72222 (10 mg/kg) and ondansetron (1.25-16 mg/kg) did not attenuate the cocaine cue. In rats trained to discriminate mCPBG from saline, the 5-HT precursor l-5-hydroxytryptophan (12.5-50 mg/kg) dose-dependently substituted for mCPBG, whereas the 5-HT3 antagonist zacopride (0.1-10 mg/kg) partially antagonized the mCPBG cue, demonstrating that mCPBG produces distinct discriminable effects that appear to be mediated by 5-HT, possibly 5-HT3, receptors. However, cocaine (5-20 mg/kg) did not substitute in mCPBG-trained rats. Overall, these data support previous findings to suggest that 5-HT3 receptors play little role in mediating the discriminative stimulus effects of cocaine and suggest that the neurochemical mechanisms and/or sites of action important for the generation of the discriminative stimulus vs. locomotor stimulatory effects of cocaine may be dissociable.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 30 条
[1]  
BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803
[2]   COCAINE INCREASES EXTRACELLULAR DOPAMINE IN RAT NUCLEUS ACCUMBENS AND VENTRAL TEGMENTAL AREA AS SHOWN BY INVIVO MICRODIALYSIS [J].
BRADBERRY, CW ;
ROTH, RH .
NEUROSCIENCE LETTERS, 1989, 103 (01) :97-102
[3]   DOPAMINE-D1 AND DOPAMINE-D2 MEDIATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-AMPHETAMINE AND COCAINE [J].
CALLAHAN, PM ;
APPEL, JB ;
CUNNINGHAM, KA .
PSYCHOPHARMACOLOGY, 1991, 103 (01) :50-55
[4]   5HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED BUT NOT AMPHETAMINE-INDUCED REWARD [J].
CARBONI, E ;
ACQUAS, E ;
LEONE, P ;
DICHIARA, G .
PSYCHOPHARMACOLOGY, 1989, 97 (02) :175-178
[5]   ACTIVATION OF 5-HT3 RECEPTOR BY 1-PHENYLBIGUANIDE INCREASES DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS [J].
CHEN, J ;
VANPRAAG, HM ;
GARDNER, EL .
BRAIN RESEARCH, 1991, 543 (02) :354-357
[6]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[7]   SITES OF ACTION OF ONDANSETRON TO INHIBIT WITHDRAWAL FROM DRUGS OF ABUSE [J].
COSTALL, B ;
JONES, BJ ;
KELLY, ME ;
NAYLOR, RJ ;
ONAIVI, ES ;
TYERS, MB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) :97-104
[8]  
COSTALL B, 1987, BRIT J PHARMACOL, V93, pP194
[9]  
De La Garza R. Ii, 1993, Society for Neuroscience Abstracts, V19, P1850
[10]   INTER-ANIMAL OLFACTORY CUES IN OPERANT DRUG DISCRIMINATION PROCEDURES IN RATS [J].
EXTANCE, K ;
GOUDIE, AJ .
PSYCHOPHARMACOLOGY, 1981, 73 (04) :363-371